Monoclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

Host

Mouse

Clone Number

Ig Isotype

IgG

Organism species

Homo sapiens (Human)

Concentration

1mg/mL

Application

WB; IHC; ICC; IP.

Alternative Names

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

Item Names

Cyclin Dependent Kinase Inhibitor 2A

Research Area

Tumor immunity;Developmental science;

Citation

Buffer Formulation

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Immunogen

RPA794Hu01-Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

Usage

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

Traits

Liquid

Purification

Protein A + Protein G affinity chromatography